<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02548663</url>
  </required_header>
  <id_info>
    <org_study_id>ME_E_SLA</org_study_id>
    <nct_id>NCT02548663</nct_id>
  </id_info>
  <brief_title>Sport Therapy and Osteopathy Manipulative Treatment in ALS</brief_title>
  <acronym>ME_E_SLA</acronym>
  <official_title>Sport Therapy for Contrasting the Deterioration of Muscle Oxidative Metabolism in Patients Affected by Amyotrophic Lateral Sclerosis (ALS) - Project ME_E_SLA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milano Bicocca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Italian Academy of Osteopathic Medicine (AIMO), Saronno, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Milano Bicocca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project assessed muscle oxidative metabolism and fatigue in patients affected by
      amyotrophic lateral sclerosis (ALS) undergoing to three months of individualized
      cardiovascular and strength training. Muscle oxidative metabolism and strength will be
      assessed by non-invasive methods, such as near-infrared spectroscopy (NIRS) and
      mechanomyography (MMG). NIRS is a technique giving indications on the capacity of oxygen
      extraction of muscles during exercise. MMG allows analyzing the pattern of motor unit
      recruitment and related fatigue. The investigators will also assess the effects of training
      on pain tolerance and quality of life (QoL) by the Brief Pain Inventory and the McGill
      Quality of Life questionnaires, using the validated Italian versions. Patients will be
      assessed longitudinally before (time T0) and after three months of individualized training
      (time T1). After one month of de-training (time T2) the investigators will assess the
      hypothetic persistence of any treatment-related effect. The effect of three
      months-osteopathic treatment (osteo) on pain and QoL will be assessed as well.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single blind pilot trial assessing the efficacy and side effects of active training or
      osteopathic manipulative treatment in ALS.

      Interventions will be administered for three months (plus one month without intervention) by
      specialized personnel.

      Primary outcome measures will include: exercise tolerance and muscle oxygen extraction
      capacity, side effects. Secondary outcome measures will include: pain, QoL and disease
      progression scales.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in the relationship between maximal oxygen consumption (VO2max) and muscle oxygen extraction capacity at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>exercise tolerance assessed by Cardio pulmonary Exercise Test (CPET); oxygen extraction on vastus lateralis, respiratory muscle and hand thenar eminence muscles assessed by Near Infrared Spectroscopy (NIRS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>appearance of side effects during the period of intervention administration</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of pain at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>Brief Pain Inventory (BPI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of quality of life at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>McGill Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of the neurological functional status at 12 weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>ALS Functional Rating Scale-revised (ALSFRS-R)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <arm_group>
    <arm_group_label>active; sport therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>active exercise carefully calibrated on residual capacities.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>passive; osteopathic treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>manipulative treatment according to osteopathic principles.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sport therapy</intervention_name>
    <description>Frequency: 60 min three times/week
20 min: aerobic training on bicycle ergometer.
20 min: strength training at 60% of maximal load.
20 min: proprioception and stretching exercises.</description>
    <arm_group_label>active; sport therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Osteopathic treatment</intervention_name>
    <description>Frequency: 60 min weekly</description>
    <arm_group_label>passive; osteopathic treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of ALS

          -  early stages of disease

          -  able to perform exercise with major muscle groups.

        Exclusion Criteria:

          -  non-invasive ventilation (NIV)

          -  tracheostomy

          -  coronaropathy

          -  ongoing infectious diseases

          -  cognitive deficits.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesca Lanfranconi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milano Bicocca</affiliation>
  </overall_official>
  <reference>
    <citation>Arbesman M, Sheard K. Systematic review of the effectiveness of occupational therapy-related interventions for people with amyotrophic lateral sclerosis. Am J Occup Ther. 2014 Jan-Feb;68(1):20-6. doi: 10.5014/ajot.2014.008649. Review.</citation>
    <PMID>24367951</PMID>
  </reference>
  <reference>
    <citation>Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis. A case report. Phys Ther. 1983 Jun;63(6):965-8.</citation>
    <PMID>6856684</PMID>
  </reference>
  <reference>
    <citation>Caraceni A, Mendoza TR, Mencaglia E, Baratella C, Edwards K, Forjaz MJ, Martini C, Serlin RC, de Conno F, Cleeland CS. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996 Apr;65(1):87-92.</citation>
    <PMID>8826494</PMID>
  </reference>
  <reference>
    <citation>Carilho R, de Carvalho M, Swash M, Pinto S, Pinto A, Costa J. Vascular endothelial growth factor and amyotrophic lateral sclerosis: the interplay with exercise and noninvasive ventilation. Muscle Nerve. 2014 Apr;49(4):545-50. doi: 10.1002/mus.23955.</citation>
    <PMID>23868282</PMID>
  </reference>
  <reference>
    <citation>Carreras I, Yuruker S, Aytan N, Hossain L, Choi JK, Jenkins BG, Kowall NW, Dedeoglu A. Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Res. 2010 Feb 8;1313:192-201. doi: 10.1016/j.brainres.2009.11.051. Epub 2009 Dec 5.</citation>
    <PMID>19968977</PMID>
  </reference>
  <reference>
    <citation>Chiò A, Canosa A, Gallo S, Moglia C, Ilardi A, Cammarosano S, Papurello D, Calvo A. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol. 2012 Apr;19(4):551-5. doi: 10.1111/j.1468-1331.2011.03540.x. Epub 2011 Oct 4.</citation>
    <PMID>21972798</PMID>
  </reference>
  <reference>
    <citation>Colombo R, Mazzini L, Mora G, Parenzan R, Creola G, Pirali I, Minuco G. Measurement of isometric muscle strength: a reproducibility study of maximal voluntary contraction in normal subjects and amyotrophic lateral sclerosis patients. Med Eng Phys. 2000 Apr;22(3):167-74.</citation>
    <PMID>10964037</PMID>
  </reference>
  <reference>
    <citation>Dal Bello-Haas V, Florence JM. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2013 May 31;(5):CD005229. doi: 10.1002/14651858.CD005229.pub3. Review.</citation>
    <PMID>23728653</PMID>
  </reference>
  <reference>
    <citation>Bello-Haas VD, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, Pioro EP, Mitsumoto H. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology. 2007 Jun 5;68(23):2003-7.</citation>
    <PMID>17548549</PMID>
  </reference>
  <reference>
    <citation>Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, Lécolle S, Lopes P, Vidal PP, Chanoine C, Charbonnier F. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol. 2009 Jul 15;587(Pt 14):3561-72. doi: 10.1113/jphysiol.2009.169748. Epub 2009 Jun 2.</citation>
    <PMID>19491245</PMID>
  </reference>
  <reference>
    <citation>Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001 Oct 15;191(1-2):133-7.</citation>
    <PMID>11677004</PMID>
  </reference>
  <reference>
    <citation>Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol. 2003 Jun;53(6):804-7.</citation>
    <PMID>12783429</PMID>
  </reference>
  <reference>
    <citation>Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004 May;29(5):656-62.</citation>
    <PMID>15116368</PMID>
  </reference>
  <reference>
    <citation>Pinto AC, Alves M, Nogueira A, Evangelista T, Carvalho J, Coelho A, de Carvalho M, Sales-Luís ML. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci. 1999 Oct 31;169(1-2):69-75.</citation>
    <PMID>10540010</PMID>
  </reference>
  <reference>
    <citation>Veldink JH, Bär PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003 Nov;13(9):737-43.</citation>
    <PMID>14561497</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2015</study_first_submitted>
  <study_first_submitted_qc>September 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2015</study_first_posted>
  <last_update_submitted>September 14, 2015</last_update_submitted>
  <last_update_submitted_qc>September 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>amyotrophic lateral sclerosis</keyword>
  <keyword>sport therapy</keyword>
  <keyword>osteopathic manual treatment</keyword>
  <keyword>muscle oxidative metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

